Glaukos Corp公司的背景是什麼？

詳細公司背景可參考: [https://www.glaukos.com](https://www.glaukos.com)。

Glaukos Corp

GKOS

39.340

▲0.290

▲0.74%

概況消息

最少15分鐘延遲，股票資訊由第三方資訊供應商提供

・Glaukos Corp - 延遲價格・最後更新於 20/05 12:15

最高位: 40.500
最低位: 38.480
開市價: --
前收市價: 39.050
成交量(千): 14.56
成交額(百萬): 4.84
買入: --
賣出: --
每手股數: --
市值(百萬): 1,862.10
市盈率: --
息率: --
差價: --
52週高低: 87.240 - 33.330

所有資料不保證絕對正確、完整、或實時，僅作為參考使用。投資涉及風險，過往業績並不代表將來表現，作任何投資決定或交易前，閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

企業資料

公司名稱: Glaukos Corp
證券代碼: GKOS.US
所屬板塊: Medical Devices
公司業務: Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.
發行量: 47053318
公司總部: 229 Avenida Fabricante
公司網址: https://www.glaukos.com
公司電郵: clewis@glaukos.com
公司電話: +1 949 367-9600

關於

Glaukos Corp(GKOS.US)所屬的行業板塊為Medical Devices。

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

詳細公司背景可參考: https://www.glaukos.com。

快訊

資訊

虛擬市場

Glaukos Corp

企業資料

最新發佈

關於